SERMs - Raloxifene Pharmacology Information PDF
Document Details
Uploaded by DignifiedRadon
Royal Holloway, University of London
2023
Tags
Summary
This document provides information on SERMs, specifically raloxifene, covering therapeutic uses, adverse reactions, interventions, client instructions and precautions. The resource is copyright-protected by Assessment Technologies Institute, L.L.C. and focuses on medication information.
Full Transcript
Pharmacology Made Easy Medication Information Table SERMs – raloxifene Category Information THERAPEUTIC USE Postmenopausal osteoporosis—prevention and treatment...
Pharmacology Made Easy Medication Information Table SERMs – raloxifene Category Information THERAPEUTIC USE Postmenopausal osteoporosis—prevention and treatment Reduces risk of estrogen receptor-positive breast cancer ADVERSE DRUG Increased risk of deep vein thrombosis (DVT) and pulmonary emboli REACTIONS Hot flashes Stroke INTERVENTIONS Observe for manifestations of thromboembolisms. Use lightweight covers over clients. Monitor bone density. ADMINISTRATION Give orally daily. May give with or without food. CLIENT INSTRUCTIONS Contact provider if client experiences pain in calf or difficulty breathing. Do not take estrogen replacement therapy during treatment. Warn clients that hot flashes may occur. Encourage clients to consume adequate amounts of calcium and vitamin D. Encourage clients to perform weight-bearing exercises (brisk walking, stair climbing) daily. If premenopausal and using raloxifene to prevent breast cancer, use contraception and do not breastfeed during treatment. Do not take estrogen replacement therapy during treatment. CONTRAINDICATIONS Teratogenic Lactation Current and past history of deep vein thrombosis PRECAUTIONS Estrogen therapy Hyperlipidemia INTERACTIONS Concurrent administration with estrogen is not recommended. Copyright ©2023 Assessment Technologies Institute, L.L.C. All rights reserved. This resource is copyright protected material of ATI and is provided for use solely under license by ATI. Copying, distributing, or posting this material on the internet or social media is strictly prohibited. Posting on institution LMS requires ATI’s prior written permission. PAGE 1 www.atitesting.com ©2023 Assessment Technologies Institute, L.L.C.
